Sonothrombolysis.

Abstract

Ultrasound (US) applied as an adjunct to thrombolytic therapy improves the recanalization of occluded vessels, and microbubbles can amplify this effect. New data suggests that the combination of US and microbubbles without tissue plasminogen activator may achieve recanalization with a lower risk of hemorrhage. Further possibilities include specific targeting of thrombus with immunobubbles as well as local drug delivery with US-sensitive liposomes. Clinical studies support the use of US for ischemic stroke therapy, and the first trials of enhancing sonothrombolysis with microbubbles have been encouraging. One emerging clinical application is sonothrombolysis of intracranial hemorrhages for clot evacuation. Microcirculation, irrespective of recanalization, may also be improved by US and microbubbles, and this effect may open new opportunities for the application of sonothrombolysis in acute ischemic stroke. Understanding the mechanisms of therapeutic action and relating this knowledge to issues of efficacy and safety are important objectives of ongoing research. This review will discuss the translational capacities of in vitro studies and preclinical research and will assess the first clinical studies of this promising therapeutic strategy.

• Authors: Stephen Meairs
• Journal: Frontiers of neurology and neuroscience (Front Neurol Neurosci) Vol. 36 Pg. 83-93 ( 2015) ISSN: 1662-2804 [Electronic] Switzerland
• PMID: 25531665 (Publication Type: Historical Article, Journal Article, Review)
• Copyright: © 2015 S. Karger AG, Basel.

Chemical References

• Tissue Plasminogen Activator

Topics

• History, 20th Century
• Humans
• Microbubbles
• Stroke (therapy)
• Thrombosis (therapy)
• Tissue Plasminogen Activator (therapeutic use)
• Ultrasonic Therapy (history, methods)